BDNF has been shown to enhance the survival of both myeloma [41], [56], [57] and B-cell lines after serum deprivation [8], [58] whereas, anti-BDNF Ab decreased tumor growth in myeloma and neuroblastoma models [57], [59]. Here, BDNF is linked to plasma cell myeloma.